| |
| |
|
| Insider
Information: |
Christensen Jamie |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
40,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
40,600 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -183.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2014-12-05 |
0 |
Premium* |
|
|
Tango Therapeutics Ord Shs |
TNGX |
Director |
2020-09-02 |
40,600 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Science Officer |
• – – |
2018-01-16 |
4 |
OE |
$17.41 |
$188,272 |
D/D |
10,814 |
13,691 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-01-26 |
4 |
AS |
$26.11 |
$326,423 |
D/D |
(12,500) |
2,877 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-01-26 |
4 |
OE |
$5.40 |
$67,500 |
D/D |
12,500 |
15,377 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-02-06 |
4 |
OE |
$17.41 |
$488,030 |
D/D |
23,000 |
25,877 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-02-06 |
4 |
AS |
$30.00 |
$690,000 |
D/D |
(23,000) |
2,877 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-03-09 |
4 |
OE |
$17.41 |
$470,620 |
D/D |
22,000 |
24,877 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-03-09 |
4 |
AS |
$33.00 |
$726,040 |
D/D |
(22,000) |
2,877 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-06-26 |
4 |
OE |
$5.40 |
$28,123 |
D/D |
5,208 |
8,085 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-06-26 |
4 |
AS |
$48.62 |
$253,965 |
D/D |
(5,208) |
3,394 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-06-27 |
4 |
OE |
$5.50 |
$27,495 |
D/D |
4,999 |
8,393 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-06-27 |
4 |
AS |
$49.43 |
$247,665 |
D/D |
(4,999) |
3,394 |
0 |
- |
|
61 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
